Table 3.
Incidence-based mortality studies for the evaluation of mammography screening effectiveness in Denmark and in Norway.
| Years included in study | Year of screening introduction in screening areas | Age groups | BC mortality rate in the pre-screening period (historical control) | BC mortality rate in the screening period | Ratio of BC mortality rates, screening versus pre-screening perioda | Ratio of BC mortality rates, screening versus non-screening areasa | |
|---|---|---|---|---|---|---|---|
| Screening areas | No screening | Screening | |||||
| Denmark, Olsen et al. 2005 [28] | 1981 to 2001 | 1991 | 50 to 79 | 69 | 52 | 0.75 | 0.74 |
| Norway, Kalager et al. 2010 [33] | 1986 to 2005 | 1996 | 50 to 84 | 33 | 24 | 0.73 | 0.9 |
| Norway, Olsen et al. 2012 [34] | 1990 to 2008 | 1996 | 50 to 84 | 35 | 27 | 0.77 | 0.91 |
| Comparison (non-screening) areas | No screening | No screening | |||||
| Denmark, Olsen et al. 2005 [28] | 1981 to 2001 | - | 50 to 79 | 52 | 53 | 1.02 | reference |
| Norway, Kalager et al. 2010 [33] | 1986 to 2005 | - | 50 to 84 | 31 | 25 | 0.81 | reference |
| Norway, Olsen et al. 2012 [34] | 1990 to 2008 | - | 50 to 84 | 39 | 33 | 0.85 | reference |
Figures in the table are breast cancer mortality rates per 100,000 women ages 50 to 79 in Denmark and 50 to 84 in Norway. aRate ratios may slightly differ from those of the original publications reported in Table 2 due to rounding and absence of statistical modelling. BC: breast cancer; NR: not reported.